dual gip and glp-1 receptor agonist Free Comparison Chart: GIP/GLP-1 Agonists for Type 2 Diabetes π Link in bio #FOAMed #Type2Diabetes #GLP1 Frontiers | GLP-1/GIP dual agonist
Description
10.2337/ds20-0072

"In the brain, it's thought to reduce food intake by some element of appetite suppression," says Evan Nadler, MD, MBA , former co-director of the obesity program at Children's National Hospital and current adjunct associate professor at George Washington University

[DOI] [PMC free article] [PubMed] [Google Scholar] 58.Gray SM, et al

Management of hyperglycemia in type 2 diabetes, 2022

Likewise, the comparison of Wegovy vs Zepbound underscores Wegovys edge in weight loss efficacy
Yoshida Y, Joshi P, Barri S, Wang J, Corder AL, OConnell SS, et al
